Composite CA15-3, LDH, and Albumin Index as a Predictor of Survival in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine

<b>Background/Objectives</b>: Trastuzumab emtansine (T-DM1) is widely used in Human Epidermal Growth Factor Receptor2 (HER2)-positive metastatic breast cancer; however, outcomes vary, and reliable prognostic markers remain limited. We developed the CALA index as a composite biomarker integrating CA1...

Полное описание

Библиографические подробности

Главные авторы:	Nagihan Kolkıran, Atike Pınar Erdoğan, Mustafa Şahbazlar, Müge Kurul Yeniay, Sinan Ünal, Mehmet Sinan Akarca, Elif Atağ Akyürek, Özge Demirkıran, Bilgin Demir, Ferhat Ekinci
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2026-05-01
Серии:	Pharmaceuticals
Предметы:	breast cancer trastuzumab emtansine prognostic index overall survival
Online-ссылка:	https://www.mdpi.com/1424-8247/19/6/809
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!